P-228: Neonatal diabetes mellitus due to mutation in the KCNJ11 changing a child and his father’s life
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von T de Lima Vitor und 12 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
BACKGROUND:Neonatal diabetes mellitus (NDM) is a rare monogenic diabetes presenting in the first six months of life, caused by mutations that impair beta-cell function and insulin secretion. KCNJ11 variants are the main cause of permanent NDM.
Objectives
To describe a case of NDM with a heterozygous KCNJ11 mutation, highlighting clinical presentation, genetic findings, therapeutic response, and its diagnostic and treatment implications.
Methods
A 2-year-9-month-old male presented in early life with hypoactivity and reduced intake, progressing to severe diabetic ketoacidosis requiring ICU admission and mechanical ventilation. Despite basal-bolus insulin and later pump therapy, he had marked glycemic variability and recurrent hypoglycemia. Genetic testing identified a heterozygous KCNJ11 mutation, confirming NDM. Glibenclamide was initiated, resulting in progressive improvement, complete insulin withdrawal, and sustained glycemic control with adequate weight gain. Family investigation revealed that the father had a history of diabetes since childhood and was on insulin therapy, with poor glycemic control. Following the child’s diagnosis, genetic testing was performed in the father, which identified the same KCNJ11 mutation. Based on this result, insulin therapy was discontinued and sulfonylurea was initiated, leading to favorable outcomes and a significant improvement in glycemic control.
Results
Infants with early persistent hyperglycemia should undergo genetic testing for monogenic diabetes. In this case, the child’s diagnosis was crucial for identifying the mutation in the father, allowing diagnostic and therapeutic reclassification. Both were treated with sulfonylureas and achieved good glycemic control.
Conclusions
The case emphasizes early genetic diagnosis in NDM, enabling targeted therapy, insulin discontinuation, reduced glycemic variability and appropriate weight gain.
Zitieren
APA
Vitor, T. D. L., Almeida, C. M., Pavie, P. L. X. M., Fontanella, G. P., Morro, H., Cortes, C. S., Pavani, M. D. S., Brunello, A. L., Domingues, V. M., Bottura, L. H., Sarti, M. T. A., Sant’Ana, V. K. S. D., & Junior, R. L. D. R. (2026). P-228: Neonatal diabetes mellitus due to mutation in the KCNJ11 changing a child and his father’s life. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.286
Vancouver
Vitor TDL, Almeida CM, Pavie PLXM, Fontanella GP, Morro H, Cortes CS, et al. P-228: Neonatal diabetes mellitus due to mutation in the KCNJ11 changing a child and his father’s life. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.286
BibTeX
@article{Vitor2026,
author = {Vitor, T de Lima and Almeida, C Moura and Pavie, P Lemgruber Xavier Mattoso and Fontanella, G Padilha and Morro, H and Cortes, C Sousa and Pavani, M dos Santos and Brunello, A L and Domingues, V Magalhães and Bottura, L Hilário and Sarti, M T Alves and Sant’Ana, V Kiill Suazo de and Junior, R Liberatore Del Roio},
title = {P-228: Neonatal diabetes mellitus due to mutation in the KCNJ11 changing a child and his father’s life},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.286}
}
EUVIMED